home / stock / rxrx / rxrx quote
Last: | $7.16 |
---|---|
Change Percent: | 0.4% |
Open: | $7.43 |
Close: | $7.16 |
High: | $7.435 |
Low: | $7.04 |
Volume: | 6,072,266 |
Last Trade Date Time: | 07/02/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$7.16 | $7.43 | $7.16 | $7.435 | $7.04 | 6,072,266 | 07-02-2024 |
$7.46 | $7.53 | $7.46 | $7.95 | $7.39 | 8,152,214 | 07-01-2024 |
$7.5 | $7.57 | $7.5 | $7.7 | $7.1501 | 22,314,534 | 06-28-2024 |
$7.575 | $7 | $7.575 | $7.6 | $6.75 | 28,265,718 | 06-27-2024 |
$8.76 | $9.3 | $8.76 | $9.47 | $8.745 | 5,641,575 | 06-26-2024 |
$9.38 | $9.45 | $9.38 | $9.865 | $9.3 | 5,198,736 | 06-25-2024 |
$9.34 | $8.88 | $9.34 | $9.7 | $8.87 | 6,476,084 | 06-24-2024 |
$8.85 | $9.1 | $8.85 | $9.22 | $8.62 | 8,714,510 | 06-21-2024 |
$9.15 | $9.59 | $9.15 | $9.66 | $8.94 | 3,966,747 | 06-20-2024 |
$9.7 | $9.33 | $9.7 | $9.99 | $9.24 | 4,452,855 | 06-19-2024 |
$9.7 | $9.33 | $9.7 | $9.99 | $9.24 | 4,452,855 | 06-18-2024 |
$9.37 | $9.2 | $9.37 | $9.475 | $9.11 | 3,248,203 | 06-17-2024 |
$9.26 | $9.24 | $9.26 | $9.41 | $9.165 | 2,881,354 | 06-14-2024 |
$9.44 | $9.33 | $9.44 | $9.6 | $9.1201 | 3,069,077 | 06-13-2024 |
$9.3 | $8.95 | $9.3 | $9.49 | $8.9425 | 6,213,809 | 06-12-2024 |
$8.58 | $8.5 | $8.58 | $8.67 | $8.265 | 3,110,115 | 06-11-2024 |
$8.62 | $8.45 | $8.62 | $8.68 | $8.33 | 3,237,127 | 06-10-2024 |
$8.51 | $8.76 | $8.51 | $8.935 | $8.4201 | 3,878,100 | 06-07-2024 |
$9.01 | $9 | $9.01 | $9.22 | $8.7202 | 3,394,252 | 06-06-2024 |
$9.09 | $8.42 | $9.09 | $9.135 | $8.27 | 4,848,535 | 06-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Recursion Pharmaceuticals Inc. Company Name:
RXRX Stock Symbol:
NASDAQ Market:
Recursion Pharmaceuticals Inc. Website:
Salt Lake City, June 26, 2024 (GLOBE NEWSWIRE) -- Recursion Pharmaceuticals, Inc. (“ Recursion ”) (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced the pricing of its underwritten public offering of 30,769,...